Example: Healthcare Sector Outperforms in Q4 2024
Confidence Score
10/15/2024
Q4 2024 (October - December)
10/15/2024 - 12/31/2024
0 days
Thesis Details
The Event
Following the November 2024 election results and increased focus on Medicare negotiations, healthcare stocks have sold off 8% from October highs as investors price in regulatory uncertainty.
Our Hypothesis
Healthcare sector will outperform S&P 500 by 5%+ in Q4 2024 as oversold conditions and defensive positioning attract investors during typical year-end volatility.
Our Rationale
Healthcare historically shows defensive characteristics during market uncertainty. Sector is trading at 15.2x forward earnings vs 20.8x for S&P 500, representing widest discount in 3 years. Major pharma companies have strong pipelines with multiple drug approvals expected. Aging demographics provide structural tailwind. Q4 seasonality favors defensive sectors.
Tags
Measurable Data Points (4)
Healthcare ETF (XLV) Relative Performance
Percentage • manual
Target
Above 5
Current Value
2.3
Last Updated
1/8/2026
XLV vs SPY Ratio
Custom • manual
Target
Above 1.05
Current Value
1.02
Last Updated
1/8/2026
Healthcare Sector P/E Compression
Custom • manual
Target
Above 16
Current Value
15.8
Last Updated
1/7/2026
Major Pharma Revenue Beats
Custom • manual
Target
Above 3
Current Value
1
Last Updated
1/6/2026
How we score: Each data point is evaluated as "met", "on track", "off track", or "failed" based on its current value vs. target. The overall confidence score is calculated as the percentage of data points that are "met" or "on track". When a thesis is closed, the final outcome score only counts "met" data points.